Compounds > quinoxalines
Page last updated: 2024-08-17

quinoxalines and bay 58-2667

quinoxalines has been researched along with bay 58-2667 in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (77.78)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schmidt, P; Schramm, M; Schröder, H; Stasch, JP1
Rothkegel, C; Schmidt, PM; Schröder, H; Stasch, JP; Wunder, F1
Dunkern, TR; Feurstein, D; Hatzelmann, A; Rossi, GA; Sabatini, F1
Bellas, E; Bloch, KD; Buys, ES; Evgenov, NV; Evgenov, OV; Gnoth, MJ; Graveline, AR; Hess, DR; Kohane, DS; Langer, R; Liu, R; Stasch, JP; Volpato, GP; Zapol, WM1
Dismuke, WM; Ellis, DZ; Sharif, NA1
Abman, SH; Chester, M; Gien, J; Grover, TR; Seedorf, G; Tourneux, P1
Hoffmann, LS; Keim, Y; Schaefer, S; Schmidt, HH; Schmidt, PM; Stasch, JP1
Abman, SH; Chester, M; Gien, J; Grover, T; Seedorf, G; Stasch, JP; Tourneux, P; Tseng, N; Wright, J1
Busch, M; Busch, R; Dörr, M; Eckerle, LG; Felix, SB; Gross, S; Hertrich, I; Rauch, BH; Reinke, Y; Riad, A; Stasch, JP1

Other Studies

9 other study(ies) available for quinoxalines and bay 58-2667

ArticleYear
Mechanisms of nitric oxide independent activation of soluble guanylyl cyclase.
    European journal of pharmacology, 2003, May-16, Volume: 468, Issue:3

    Topics: Benzoates; Diethylamines; Enzyme Activation; Guanylate Cyclase; Heme; Morpholines; Nitric Oxide; Nitric Oxide Donors; Nitrogen Oxides; Oxadiazoles; Pyrimidines; Quinoxalines; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Spectrophotometry, Ultraviolet

2003
Residues stabilizing the heme moiety of the nitric oxide sensor soluble guanylate cyclase.
    European journal of pharmacology, 2005, Apr-18, Volume: 513, Issue:1-2

    Topics: Alanine; Amino Acid Sequence; Amino Acid Substitution; Animals; Benzoates; Binding Sites; CHO Cells; Cricetinae; Cricetulus; Cyclic GMP; Diethylamines; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Genotype; Guanylate Cyclase; Heme; Molecular Sequence Data; Mutation, Missense; Nitric Acid; Nitrogen Oxides; Oxadiazoles; Protoporphyrins; Pyrazoles; Pyridines; Quinoxalines; Sequence Homology, Amino Acid; Serine; Solubility; Transfection

2005
Inhibition of TGF-beta induced lung fibroblast to myofibroblast conversion by phosphodiesterase inhibiting drugs and activators of soluble guanylyl cyclase.
    European journal of pharmacology, 2007, Oct-15, Volume: 572, Issue:1

    Topics: Actins; Benzamides; Benzoates; Blotting, Western; Cell Differentiation; Cells, Cultured; Cyclic GMP; Dinoprostone; Drug Synergism; Enzyme Activators; Fibroblasts; Fibrosis; Guanylate Cyclase; Humans; Immunohistochemistry; Isoenzymes; Lung; Myocytes, Smooth Muscle; Natriuretic Peptide, Brain; Nitric Oxide Donors; Nitroso Compounds; Oxadiazoles; Phosphodiesterase Inhibitors; Piperazines; Purines; Pyridines; Quinoxalines; Receptors, Cytoplasmic and Nuclear; Sildenafil Citrate; Soluble Guanylyl Cyclase; Sulfones; Transforming Growth Factor beta

2007
Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation.
    American journal of respiratory and critical care medicine, 2007, Dec-01, Volume: 176, Issue:11

    Topics: Administration, Inhalation; Aerosols; Animals; Benzoates; Cyclic GMP; Dose-Response Relationship, Drug; Drug Combinations; Guanylate Cyclase; Injections, Intravenous; Lung; Morpholines; Nitric Oxide; Oxadiazoles; Particle Size; Phosphodiesterase Inhibitors; Powders; Pulmonary Circulation; Purinones; Pyrazoles; Pyridines; Pyrimidines; Quinoxalines; Receptors, Cytoplasmic and Nuclear; Sheep; Soluble Guanylyl Cyclase; Vasodilation

2007
Human trabecular meshwork cell volume decrease by NO-independent soluble guanylate cyclase activators YC-1 and BAY-58-2667 involves the BKCa ion channel.
    Investigative ophthalmology & visual science, 2009, Volume: 50, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Benzoates; Cell Size; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enzyme Activators; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Guanylate Cyclase; Humans; Indazoles; Large-Conductance Calcium-Activated Potassium Channels; Microscopy, Confocal; Nitric Oxide; Oxadiazoles; Quinoxalines; Trabecular Meshwork

2009
Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus.
    American journal of physiology. Lung cellular and molecular physiology, 2009, Volume: 297, Issue:2

    Topics: Acetylcholine; Animals; Animals, Newborn; Benzoates; Cells, Cultured; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Fetus; Gestational Age; Guanylate Cyclase; Hypertension, Pulmonary; Muscle, Smooth, Vascular; Nitric Oxide; Oxadiazoles; Pregnancy; Pulmonary Artery; Pulmonary Circulation; Pulmonary Wedge Pressure; Quinoxalines; Receptors, Cytoplasmic and Nuclear; Sheep; Soluble Guanylyl Cyclase; Vasodilation; Vasodilator Agents

2009
Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.
    British journal of pharmacology, 2009, Volume: 157, Issue:5

    Topics: Aequorin; Animals; Benzoates; Binding Sites; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Cyclic Nucleotide-Gated Cation Channels; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Activation; Enzyme Activators; Enzyme Inhibitors; Enzyme Stability; Genes, Reporter; Guanylate Cyclase; Heme; Molecular Structure; Mutation; ortho-Aminobenzoates; Oxadiazoles; Oxidation-Reduction; Protoporphyrins; Pyrazoles; Pyridines; Quinoxalines; Rats; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Structure-Activity Relationship; Sulfonamides; Swine; Transfection

2009
Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension.
    American journal of physiology. Lung cellular and molecular physiology, 2011, Volume: 301, Issue:5

    Topics: Animals; Benzoates; Cells, Cultured; Cyclic GMP; Disease Models, Animal; Female; Fetus; Guanylate Cyclase; Humans; Hydrogen Peroxide; Infant, Newborn; Isoenzymes; Myocytes, Smooth Muscle; Nitric Oxide; Nitroprusside; Oxadiazoles; Persistent Fetal Circulation Syndrome; Pregnancy; Pulmonary Artery; Pulmonary Circulation; Quinoxalines; Receptors, Cytoplasmic and Nuclear; Sheep; Soluble Guanylyl Cyclase; Vascular Resistance; Vasodilation; Vasodilator Agents

2011
The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
    European journal of pharmacology, 2015, Nov-15, Volume: 767

    Topics: Animals; Benzoates; Calcium; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Drug Synergism; Electric Stimulation; Female; Guanylate Cyclase; Isoproterenol; Muscle Relaxation; Myocardial Contraction; Myocytes, Cardiac; Oxadiazoles; Pyrazoles; Pyrimidines; Quinoxalines; Rats; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Thionucleotides; Verapamil

2015